Wolverine Asset Management LLC increased its holdings in Aimei Health Technology Co., Ltd (NASDAQ:AFJK - Free Report) by 21.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 654,039 shares of the company's stock after purchasing an additional 115,000 shares during the quarter. Wolverine Asset Management LLC owned 7.24% of Aimei Health Technology worth $6,998,000 at the end of the most recent quarter.
Several other institutional investors also recently modified their holdings of the stock. Virtu Financial LLC acquired a new stake in shares of Aimei Health Technology during the third quarter valued at approximately $123,000. Rivernorth Capital Management LLC lifted its stake in Aimei Health Technology by 9.1% in the third quarter. Rivernorth Capital Management LLC now owns 172,789 shares of the company's stock valued at $1,811,000 after acquiring an additional 14,391 shares during the last quarter. Glazer Capital LLC lifted its stake in shares of Aimei Health Technology by 3.4% in the 3rd quarter. Glazer Capital LLC now owns 608,670 shares of the company's stock valued at $6,379,000 after purchasing an additional 19,896 shares during the last quarter. Finally, Mizuho Securities USA LLC lifted its position in shares of Aimei Health Technology by 60.7% in the third quarter. Mizuho Securities USA LLC now owns 442,778 shares of the company's stock worth $4,627,000 after buying an additional 167,223 shares during the last quarter. Institutional investors own 45.58% of the company's stock.
Aimei Health Technology Price Performance
AFJK stock traded up $0.03 during midday trading on Tuesday, hitting $10.93. Aimei Health Technology Co., Ltd has a 1-year low of $10.15 and a 1-year high of $11.00. The firm's 50 day moving average is $10.76 and its 200 day moving average is $10.60.
Aimei Health Technology Company Profile
(
Free Report)
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Recommended Stories
Before you consider Aimei Health Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aimei Health Technology wasn't on the list.
While Aimei Health Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
